Zymera Licenses Life Technologies' Qdot Technology | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said today that Zymera has licensed its quantum dot intellectual property portfolio.

Zymera plans to use the Qdot nanocrystals to create self-illuminating quantum dot products that will be used in in vivo imaging, biomarker discovery, and in biosensing applications. Zymera's self-illumination technology uses bioluminescence resonance energy transfer, to transfer light from bioluminescent proteins, such as luciferase, onto quantum dots.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.